Current role of vigabatrin in infantile spasms.

[1]  Douglas L. Rothman,et al.  Acute regulation of steady-state GABA levels following GABA-transaminase inhibition in rat cerebral cortex , 2006, Neurochemistry International.

[2]  P. Curatolo,et al.  Current management for epilepsy in tuberous sclerosis complex , 2006, Current opinion in neurology.

[3]  G. Cavalleri,et al.  Vigabatrin Retinopathy in an Irish Cohort: Lack of Correlation with Dose , 2006, Epilepsia.

[4]  B. Karapinar,et al.  Vigabatrin Caused Rapidly Progressive Deterioration in Two Cases With Early Myoclonic Encephalopathy Associated With Nonketotic Hyperglycinemia , 2006, Journal of child neurology.

[5]  B. Harding,et al.  Taylor‐type Focal Cortical Dysplasia in Infants: Some MRI Lesions Almost Disappear with Maturation of Myelination , 2005, Epilepsia.

[6]  J. Osborne,et al.  The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial , 2005, The Lancet Neurology.

[7]  M. Calcagnotto,et al.  Dysfunction of Synaptic Inhibition in Epilepsy Associated with Focal Cortical Dysplasia , 2005, The Journal of Neuroscience.

[8]  C. V. van Rijn,et al.  Vigabatrin in Low Doses Selectively Suppresses the Clonic Component of Audiogenically Kindled Seizures in Rats , 2005, Epilepsia.

[9]  R. Riikonen.  The latest on infantile spasms , 2005, Current opinion in neurology.

[10]  J. Frost,et al.  Pathogenesis of Infantile Spasms: A Model Based on Developmental Desynchronization , 2005, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[11]  J. Acheson,et al.  The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication , 2005, Eye.

[12]  Anthony L. Johnson,et al.  The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial , 2004, The Lancet.

[13]  C. Westall,et al.  Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children. , 2004, Ophthalmology.

[14]  N. Gordon.  Succinic semialdehyde dehydrogenase deficiency (SSADH) (4-hydroxybutyric aciduria, gamma-hydroxybutyric aciduria). , 2004, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[15]  B. Schmitz,et al.  Are vigabatrin-associated visual field constrictions asymptomatic? , 2004, Journal of Neurology.

[16]  M. Manfredi,et al.  Scotopic threshold response changes after vigabatrin therapy in a child without visual field defects: a new electroretinographic marker of early damage? , 2004, Neurobiology of Disease.

[17]  L. Gränse,et al.  Alterations in electroretinograms and retinal morphology in rabbits treated with vigabatrin , 2004, Documenta Ophthalmologica.

[18]  L. Frisén.  Vigabatrin-associated loss of vision: rarebit perimetry illuminates the dose-damage relationship. , 2004, Acta ophthalmologica Scandinavica.

[19]  G. Harding,et al.  Examining visual field defects in the paediatric population exposed to vigabatrin , 2003, Documenta Ophthalmologica.

[20]  F. Ascaso,et al.  Visual field defects in pediatric patients on vigabatrin monotherapy , 2003, Documenta Ophthalmologica.

[21]  G. Dutton,et al.  Peripheral retinal dysfunction in patients taking vigabatrin , 2003, Neurology.

[22]  P. Camfield,et al.  Infantile Spasms in Remission May Reemerge as Intractable Epileptic Spasms , 2003, Epilepsia.

[23]  K. Malmgren,et al.  Characterization of vigabatrin-associated optic atrophy. , 2003, Acta ophthalmologica Scandinavica.

[24]  S. Seri,et al.  Short‐term Nonhormonal and Nonsteroid Treatment in West Syndrome , 2003, Epilepsia.

[25]  A. Gropman.  Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency , 2003, Annals of neurology.

[26]  O. Dulac,et al.  Characteristics of epilepsy in focal cortical dysplasia in infancy , 2002, Epilepsy Research.

[27]  W. Mitchell,et al.  Vigabatrin for infantile spasms. , 2002, Pediatric neurology.

[28]  L Tassi,et al.  Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. , 2002, Brain : a journal of neurology.

[29]  S. Vanhatalo,et al.  Visual Field Constriction in 91 Finnish Children Treated with Vigabatrin , 2002, Epilepsia.

[30]  B. Schmitz,et al.  Is visual field constriction in epilepsy patients treated with vigabatrin reversible? , 2002, Journal of Neurology.

[31]  G. Harding,et al.  Field-specific visual-evoked potentials: Identifying field defects in vigabatrin-treated children , 2002, Neurology.

[32]  H. Vinters.  Histopathology of brain tissue from patients with infantile spasms. , 2002, International review of neurobiology.

[33]  P. Curatolo,et al.  Tuberous sclerosis complex: a review of neurological aspects. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[34]  L. Laroche,et al.  Étude du champ visuel et traitement par vigabatrin chez l'enfant , 2001 .

[35]  O. Dulac,et al.  Infantile Spasms in Down Syndrome: Good Response to a Short Course of Vigabatrin , 2001, Epilepsia.

[36]  S. Vanhatalo,et al.  Reversed visual field constrictions in children after vigabatrin withdrawal—true retinal recovery or improved test performance only? , 2001, Seizure.

[37]  J. Crompton,et al.  Visual field loss associated with vigabatrin: pathological correlations , 2001, Journal of neurology, neurosurgery, and psychiatry.

[38]  R. Nabbout.  A Risk-Benefit Assessment of Treatments for Infantile Spasms , 2001, Drug safety.

[39]  C Barber,et al.  Electro‐Oculography, Electroretinography, Visual Evoked Potentials, and Multifocal Electroretinography in Patients with Vigabatrin‐Attributed Visual Field Constriction , 2000, Epilepsia.

[40]  G. Gobbi,et al.  Visual field defects associated with vigabatrin monotherapy in children , 2000, Journal of Neurology Neurosurgery & Psychiatry.

[41]  U. Raucci,et al.  Visual Field Constriction in Children With Epilepsy on Vigabatrin Treatment , 2000, Pediatrics.

[42]  G. Harding,et al.  Separating the retinal electrophysiologic effects of vigabatrin , 2000, Neurology.

[43]  E. Shahar,et al.  Visual impairment in children with epilepsy treated with vigabatrin , 2000, Annals of neurology.

[44]  A. Vignoli,et al.  Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: is young age a favorable factor? , 2000, Neurological Sciences.

[45]  M. São Bento,et al.  [Acute psychotic disorder associated with vigabatrin]. , 2000, Acta medica portuguesa.

[46]  D. Mackey,et al.  Vigabatrin-associated visual field defects in children , 2000, Eye.

[47]  G. Krauss,et al.  Visual dysfunction in patients receiving vigabatrin , 1999, Neurology.

[48]  G. Harding,et al.  Characteristics of a Unique Visual Field Defect Attributed to Vigabatrin , 1999, Epilepsia.

[49]  G. Harding,et al.  Visual field defects associated with vigabatrin therapy , 1999, Journal of neurology, neurosurgery, and psychiatry.

[50]  A. Peters,et al.  Randomised, Placebo‐Controlled Study of Vigabatrin as First‐Line Treatment of Infantile Spasms , 1999, Epilepsia.

[51]  M. Versino,et al.  Reversibility of vigabatrin-induced visual-field defect , 1999, The Lancet.

[52]  J. Osborne,et al.  Topical Review: Vigabatrin in the Treatment of Infantile Spasms in Tuberous Sclerosis: Literature Review , 1999, Journal of child neurology.

[53]  G. Krauss,et al.  Vigabatrin-associated retinal cone system dysfunction , 1998, Neurology.

[54]  G. Krauss,et al.  Vigabatrin-associated retinal cone system dysfunction , 1998, Neurology.

[55]  M. Cilio,et al.  Vigabatrin Versus ACTH as First‐Line Treatment for Infantile Spasms: A Randomized, Prospective Study , 1997, Epilepsia.

[56]  T Eke,et al.  Retrospective study of concussive convulsions in elite Australian rules and rugby league footballers: phenomenology, aetiology, and outcome , 1997, BMJ.

[57]  J. Aicardi,et al.  Vigabatrin as Initial Therapy for Infantile Spasms: A European Retrospective Survey , 1996, Epilepsia.

[58]  Robert Appleton.  Vigabatrin in the management of generalized seizures in children , 1995, Seizure.

[59]  E. Boltshauser,et al.  Vigabatrin in newly diagnosed infantile spasms. , 1994, Neuropediatrics.

[60]  J. Vles,et al.  Vigabatrin in the Treatment of Infantile Spasms , 1993, Neuropediatrics.

[61]  O. Dulac,et al.  Therapeutic Trial of Vigabatrin in Refractory Infantile Spasms , 1991, Journal of child neurology.

[62]  O. Dulac,et al.  Vigabatrin in infantile spasms , 1990, The Lancet.